GlobeNewswire Inc.·21h ago·NaXORTX Bolsters Kidney Disease Pipeline With $3M Vectus AcquisitionXORTX acquires Vectus kidney fibrosis asset VB4-P5 for $3M, expanding pipeline in high-potential CKD therapeutics market. XRTXacquisitionkidney disease
GlobeNewswire Inc.··Na